Align Ornithine aminotransferase; Orn-AT; Lysine aminotransferase; Lys-AT; EC 2.6.1.13; EC 2.6.1.36 (characterized)
to candidate GFF3766 HP15_3708 4-aminobutyrate aminotransferase
Query= SwissProt::Q5JEW1 (445 letters) >FitnessBrowser__Marino:GFF3766 Length = 425 Score = 264 bits (674), Expect = 5e-75 Identities = 157/433 (36%), Positives = 235/433 (54%), Gaps = 22/433 (5%) Query: 16 KEVIERNFKYLAMTTQDPENLPIVIERGEGIRVYDVDGNVFYDFASGVGVINVGHSHPRV 75 KE+ +Y+A P + ++D DG DFA G+GV+N+GH HP+V Sbjct: 4 KELQALKERYVAAGAASPNEQ--FADHATNAELWDADGKRMIDFAGGIGVLNIGHRHPKV 61 Query: 76 VEAIKKQAEKFTHYSLTDFFYENAIILAEKLIELAPGDIERKVVYGNSGAEANEAAMKLV 135 VEA+K Q +K H T YE + LAEKL + P KV+ NSGAEA E AMK+ Sbjct: 62 VEAVKAQLDKLMHTCQTVMPYEGYVKLAEKLSGVVPVRGHAKVMLANSGAEALENAMKIA 121 Query: 136 KYGTGRKQFLAFYHAFHGRTQAVLSLTASKWVQQDGFFPTMPG-VTHIPYPNPYRNTWGI 194 + TG+ + F +HGRT +++ Q F P MPG V PYP PY Sbjct: 122 RAATGKTNVICFDGGYHGRTFYTMAMNGKAAPYQTDFGP-MPGTVYRAPYPVPYH----- 175 Query: 195 DGYEEPDELTNRVLDFIEEYVFRHVPPHEIGAIFFEPIQGEGGYVVPPKGFFKALKKFAD 254 G E + L ++ + P H AI EP+ GEGG+ P F K ++K D Sbjct: 176 -GVSEDEALRG-----LKMAMKADSPAHNTAAIVIEPVLGEGGFYAAPTSFLKEIRKICD 229 Query: 255 EYGILLADDEVQMGIGRTGKFWAIEHFGVEPDLIQFGKAIGGGLPLAGVIHRADITFDKP 314 E IL+ DEVQ G GRTGK +AIEH GVEPDL+ K++ G+P++ ++ D D Sbjct: 230 ENDILMIADEVQSGFGRTGKMFAIEHSGVEPDLMTMAKSMADGMPISAIV-GTDKYMDAS 288 Query: 315 GRHAT--TFGGNPVAIAAGIEVVEIVKE--LLPHVQEVGDYLHKYLEEFKEKYEVIGDAR 370 G ++ T+ G+P A AA + V ++ KE +L Q +G+ L + +++E++ + + R Sbjct: 289 GPNSLGGTYTGSPTACAAALAVFDVFKEEDILGKSQALGEKLKQRFSQWQEQFAHVDNVR 348 Query: 371 GLGLAQAVEIVKSKETKEKYPELRDRIVKESAKRGLVLLGCG--DNSIRFIPPLIVTKEE 428 LG A E+V+SKE++ PEL + K++ ++GL+LL CG N++RF+ P+ + E Sbjct: 349 NLGPMAAFELVESKESRTPKPELAAAVTKKAKEKGLILLSCGMYGNTLRFLMPVTIEDEV 408 Query: 429 IDVAMEIFEEALK 441 ++ + I EE+LK Sbjct: 409 LEEGLAIVEESLK 421 Lambda K H 0.320 0.141 0.418 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 528 Number of extensions: 24 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 445 Length of database: 425 Length adjustment: 32 Effective length of query: 413 Effective length of database: 393 Effective search space: 162309 Effective search space used: 162309 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory